セレコキシブの世界市場:製品別(50mg、100mg、200mg、400mg)、エンドユーザー・用途別(関節リウマチ、骨関節炎、急性疼痛、筋骨格痛)、地域別予測

◆英語タイトル:Global Celecoxib Market Size study, by Product (50mg Celecoxib, 100mg Celecoxib, 200mg Celecoxib, 400mg Celecoxib), by End-User/Application (Rheumatoid Arthritis, Osteoarthritis, Acute Pain, Musculoskeletal Pain) and Regional Forecasts 2018-2025
◆商品コード:BZW9JN021
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2018年12月31日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥422,650見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD5,550 ⇒換算¥593,850見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本資料は、セレコキシブの世界市場について調べ、セレコキシブの世界規模、市場動向、市場環境、製品別(50mg、100mg、200mg、400mg)分析、エンドユーザー・用途別(関節リウマチ、骨関節炎、急性疼痛、筋骨格痛)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはPfizer. 、Shire、Teva、Mylan、Chengdu Suncadia Pharmaceutical、Jiangsu Chiatai Qingjiang Pharmaceutical、Anhui Heyi Chemicalなどです。
・イントロダクション
・エグゼクティブサマリー
・セレコキシブの世界市場概要
・セレコキシブの世界市場環境
・セレコキシブの世界市場動向
・セレコキシブの世界市場規模
・セレコキシブの世界市場規模:製品別(50mg、100mg、200mg、400mg)
・セレコキシブの世界市場規模:エンドユーザー・用途別(関節リウマチ、骨関節炎、急性疼痛、筋骨格痛)
・セレコキシブの世界市場:地域別市場規模・分析
・セレコキシブの北米市場規模・予測
・セレコキシブのアメリカ市場規模・予測
・セレコキシブのヨーロッパ市場規模・予測
・セレコキシブのアジア市場規模・予測
・セレコキシブの日本市場規模・予測
・セレコキシブの中国市場規模・予測
・関連企業情報
【レポートの概要】

Global Celecoxib Market to reach USD XX billion by 2025.

Global Celecoxib Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The Celecoxib Market is continuously growing in global scenario over the coming years. The major driving factor of global Celecoxib market is increasing prevalence of acute pains and musculoskeletal pain in adults. Acute pain and musculoskeletal pain are necessary to treat as they affect the body of humans which results in positive impact in the growth of the market. Moreover, growing demand from end user industries is also a factor which drives the market of celecoxib. The one of the major restraining factor of global celecoxib market is restrictive use of its relative complications. Celecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug. It is used to treat the pain and inflammation of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain in adult, painful menstruation and juvenile rheumatoid arthritis in people two years or older. Celecoxib is available by prescription in capsule form. Celecoxib offers various advantages such as it provides relief in pains, reduce swelling, reduce stiffness & discomfort associated with diseases and safe to use at higher risk for stomach related side effects. The regional analysis of Global Celecoxib Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
+K19
The major market player included in this report are:
• Pfizer.
• Shire
• Teva
• Mylan
• Chengdu Suncadia Pharmaceutical
• Jiangsu Chiatai Qingjiang Pharmaceutical
• Anhui Heyi Chemical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

 50mg Celecoxib
 100mg Celecoxib
 200mg Celecoxib
 400mg Celecoxib

By End-User/Application:

 Rheumatoid Arthritis
 Osteoarthritis
 Acute Pain
 Musculoskeletal Pain

By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Celecoxib Market in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

TABLE OF CONTENTS

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. Celecoxib Market, by Product, 2015-2025 (USD Billion)
1.3.2. Celecoxib Market, by End-User/Application, 2015-2025 (USD Billion)
1.3.3. Celecoxib Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Celecoxib Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Celecoxib Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Celecoxib Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
Chapter 5. Celecoxib Market, by Product
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Key Market Players
5.4. Celecoxib Market, Sub Segment Analysis
5.4.1. 50mg Celecoxib
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. 100mg Celecoxib
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.3. 200mg Celecoxib
5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.4. 400mg Celecoxib
5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. Celecoxib Market, by End-User/Application
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Key Market Players
6.4. Celecoxib Market, Sub Segment Analysis
6.4.1. Rheumatoid Arthritis
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. Osteoarthritis
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Acute Pain
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Musculoskeletal Pain
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.5. Others
6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. Celecoxib Market, by Regional Analysis
7.1. Celecoxib Market, Regional Market Snapshot (2015-2025)
7.2. North America Celecoxib Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3. Europe Celecoxib Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. France
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Rest of Europe
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4. Asia Celecoxib Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5. Latin America Celecoxib Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6. Rest of The World
7.6.1. South America
7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2. Middle East and Africa
7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Pfizer.
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Shire
8.3.3. Teva
8.3.4. Mylan
8.3.5. Chengdu Suncadia Pharmaceutical
8.3.6. Jiangsu Chiatai Qingjiang Pharmaceutical
8.3.7. Anhui Heyi Chemical
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF CELECOXIB MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF CELECOXIB MARKET
TABLE 3. CELECOXIB MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. CELECOXIB MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7. CELECOXIB MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
TABLE 8. CELECOXIB MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 9. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 10. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 38. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 40. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 42. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43. CELECOXIB MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 44. CELECOXIB MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45. U.S. CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 46. U.S. CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47. U.S. CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. U.S. CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49. U.S. CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50. CANADA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 51. CANADA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. CANADA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53. CANADA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. CANADA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 55. UK CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 56. UK CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57. UK CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. UK CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59. UK CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60. GERMANY CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 61. GERMANY CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. GERMANY CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63. GERMANY CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. GERMANY CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 65. ROE CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 66. ROE CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67. ROE CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROE CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69. ROE CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 70. CHINA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 71. CHINA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. CHINA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73. CHINA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74. CHINA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75. INDIA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 76. INDIA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77. INDIA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78. INDIA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. INDIA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80. JAPAN CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 81. JAPAN CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82. JAPAN CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83. JAPAN CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 84. JAPAN CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 85. ROAPAC CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 86. ROAPAC CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 87. ROAPAC CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 88. ROAPAC CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 89. ROAPAC CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 90. BRAZIL CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 91. BRAZIL CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 92. BRAZIL CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 93. BRAZIL CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 94. BRAZIL CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 95. MEXICO CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 96. MEXICO CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 97. MEXICO CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 98. MEXICO CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 99. MEXICO CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 100. ROLA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 101. ROLA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 102. ROLA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 103. ROLA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 104. ROLA CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 105. ROW CELECOXIB MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 106. ROW CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 107. ROW CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 108. ROW CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 109. ROW CELECOXIB MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

FIG 1. CELECOXIB MARKET, RESEARCH METHODOLOGY
FIG 2. CELECOXIB MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. CELECOXIB MARKET, KEY TRENDS 2016
FIG 5. CELECOXIB MARKET, GROWTH PROSPECTS 2017-2025
FIG 6. CELECOXIB MARKET, PORTERS 5 FORCE MODEL
FIG 7. CELECOXIB MARKET, PEST ANALYSIS
FIG 8. CELECOXIB MARKET, VALUE CHAIN ANALYSIS
FIG 9. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 10. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 11. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 12. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 13. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 14. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 15. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 16. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 17. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 18. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 19. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 20. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 21. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 22. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 23. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 24. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 25. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 26. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 27. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 28. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 29. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 30. CELECOXIB MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 31. CELECOXIB MARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 32. NORTH AMERICA CELECOXIB MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 33. EUROPE CELECOXIB MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 34. ASIA PACIFIC CELECOXIB MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 35. LATIN AMERICA CELECOXIB MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 36. CELECOXIB MARKET, COMPANY MARKET SHARE ANALYSIS (2016)

【掲載企業】

Pfizer. 、Shire、Teva、Mylan、Chengdu Suncadia Pharmaceutical、Jiangsu Chiatai Qingjiang Pharmaceutical、Anhui Heyi Chemical

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[セレコキシブの世界市場:製品別(50mg、100mg、200mg、400mg)、エンドユーザー・用途別(関節リウマチ、骨関節炎、急性疼痛、筋骨格痛)、地域別予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆